Safety and efficacy of gene transfer for Leber's congenital amaurosis

Albert M. Maguire, Francesca Simonelli, Eric A. Pierce, Edward N Pugh Jr, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen A. Marshall, Francesco Testa, Enrico M. Surace, Settimio Rossi, Arkady Lyubarsky, Valder R. Arruda, Barbara Konkle, Edwin Stone, Junwei Sun, Jonathan Jacobs, Lou Dell'Osso, Richard Hertle, Jian Xing Ma & 12 others T. Michael Redmond, Xiaosong Zhu, Bernd Hauck, Olga Zelenaia, Kenneth S. Shindler, Maureen G. Maguire, J. Fraser Wright, Nicholas J. Volpe, Jennifer Wellman McDonnell, Alberto Auricchio, Katherine A. High, Jean Bennett

Research output: Contribution to journalArticle

1426 Citations (Scopus)

Abstract

Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and although the occurrence was considered to be an adverse event, the patient had some return of retinal function. Although the follow-up was very short and normal vision was not achieved, this study provides the basis for further gene therapy studies in patients with LCA.

Original languageEnglish (US)
Pages (from-to)2240-2248
Number of pages9
JournalNew England Journal of Medicine
Volume358
Issue number21
DOIs
StatePublished - May 22 2008
Externally publishedYes

Fingerprint

Leber Congenital Amaurosis
Safety
Retinal Pigment Epithelium
Genes
Dependovirus
Retinal Perforations
Genetic Therapy
Visual Acuity
Proteins
Complementary DNA
Mutation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh Jr, E. N., Mingozzi, F., Bennicelli, J., ... Bennett, J. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. New England Journal of Medicine, 358(21), 2240-2248. https://doi.org/10.1056/NEJMoa0802315

Safety and efficacy of gene transfer for Leber's congenital amaurosis. / Maguire, Albert M.; Simonelli, Francesca; Pierce, Eric A.; Pugh Jr, Edward N; Mingozzi, Federico; Bennicelli, Jeannette; Banfi, Sandro; Marshall, Kathleen A.; Testa, Francesco; Surace, Enrico M.; Rossi, Settimio; Lyubarsky, Arkady; Arruda, Valder R.; Konkle, Barbara; Stone, Edwin; Sun, Junwei; Jacobs, Jonathan; Dell'Osso, Lou; Hertle, Richard; Ma, Jian Xing; Redmond, T. Michael; Zhu, Xiaosong; Hauck, Bernd; Zelenaia, Olga; Shindler, Kenneth S.; Maguire, Maureen G.; Wright, J. Fraser; Volpe, Nicholas J.; McDonnell, Jennifer Wellman; Auricchio, Alberto; High, Katherine A.; Bennett, Jean.

In: New England Journal of Medicine, Vol. 358, No. 21, 22.05.2008, p. 2240-2248.

Research output: Contribution to journalArticle

Maguire, AM, Simonelli, F, Pierce, EA, Pugh Jr, EN, Mingozzi, F, Bennicelli, J, Banfi, S, Marshall, KA, Testa, F, Surace, EM, Rossi, S, Lyubarsky, A, Arruda, VR, Konkle, B, Stone, E, Sun, J, Jacobs, J, Dell'Osso, L, Hertle, R, Ma, JX, Redmond, TM, Zhu, X, Hauck, B, Zelenaia, O, Shindler, KS, Maguire, MG, Wright, JF, Volpe, NJ, McDonnell, JW, Auricchio, A, High, KA & Bennett, J 2008, 'Safety and efficacy of gene transfer for Leber's congenital amaurosis', New England Journal of Medicine, vol. 358, no. 21, pp. 2240-2248. https://doi.org/10.1056/NEJMoa0802315
Maguire AM, Simonelli F, Pierce EA, Pugh Jr EN, Mingozzi F, Bennicelli J et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. New England Journal of Medicine. 2008 May 22;358(21):2240-2248. https://doi.org/10.1056/NEJMoa0802315
Maguire, Albert M. ; Simonelli, Francesca ; Pierce, Eric A. ; Pugh Jr, Edward N ; Mingozzi, Federico ; Bennicelli, Jeannette ; Banfi, Sandro ; Marshall, Kathleen A. ; Testa, Francesco ; Surace, Enrico M. ; Rossi, Settimio ; Lyubarsky, Arkady ; Arruda, Valder R. ; Konkle, Barbara ; Stone, Edwin ; Sun, Junwei ; Jacobs, Jonathan ; Dell'Osso, Lou ; Hertle, Richard ; Ma, Jian Xing ; Redmond, T. Michael ; Zhu, Xiaosong ; Hauck, Bernd ; Zelenaia, Olga ; Shindler, Kenneth S. ; Maguire, Maureen G. ; Wright, J. Fraser ; Volpe, Nicholas J. ; McDonnell, Jennifer Wellman ; Auricchio, Alberto ; High, Katherine A. ; Bennett, Jean. / Safety and efficacy of gene transfer for Leber's congenital amaurosis. In: New England Journal of Medicine. 2008 ; Vol. 358, No. 21. pp. 2240-2248.
@article{98fae33ddbf549af82f1cd7d525d8c35,
title = "Safety and efficacy of gene transfer for Leber's congenital amaurosis",
abstract = "Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and although the occurrence was considered to be an adverse event, the patient had some return of retinal function. Although the follow-up was very short and normal vision was not achieved, this study provides the basis for further gene therapy studies in patients with LCA.",
author = "Maguire, {Albert M.} and Francesca Simonelli and Pierce, {Eric A.} and {Pugh Jr}, {Edward N} and Federico Mingozzi and Jeannette Bennicelli and Sandro Banfi and Marshall, {Kathleen A.} and Francesco Testa and Surace, {Enrico M.} and Settimio Rossi and Arkady Lyubarsky and Arruda, {Valder R.} and Barbara Konkle and Edwin Stone and Junwei Sun and Jonathan Jacobs and Lou Dell'Osso and Richard Hertle and Ma, {Jian Xing} and Redmond, {T. Michael} and Xiaosong Zhu and Bernd Hauck and Olga Zelenaia and Shindler, {Kenneth S.} and Maguire, {Maureen G.} and Wright, {J. Fraser} and Volpe, {Nicholas J.} and McDonnell, {Jennifer Wellman} and Alberto Auricchio and High, {Katherine A.} and Jean Bennett",
year = "2008",
month = "5",
day = "22",
doi = "10.1056/NEJMoa0802315",
language = "English (US)",
volume = "358",
pages = "2240--2248",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "21",

}

TY - JOUR

T1 - Safety and efficacy of gene transfer for Leber's congenital amaurosis

AU - Maguire, Albert M.

AU - Simonelli, Francesca

AU - Pierce, Eric A.

AU - Pugh Jr, Edward N

AU - Mingozzi, Federico

AU - Bennicelli, Jeannette

AU - Banfi, Sandro

AU - Marshall, Kathleen A.

AU - Testa, Francesco

AU - Surace, Enrico M.

AU - Rossi, Settimio

AU - Lyubarsky, Arkady

AU - Arruda, Valder R.

AU - Konkle, Barbara

AU - Stone, Edwin

AU - Sun, Junwei

AU - Jacobs, Jonathan

AU - Dell'Osso, Lou

AU - Hertle, Richard

AU - Ma, Jian Xing

AU - Redmond, T. Michael

AU - Zhu, Xiaosong

AU - Hauck, Bernd

AU - Zelenaia, Olga

AU - Shindler, Kenneth S.

AU - Maguire, Maureen G.

AU - Wright, J. Fraser

AU - Volpe, Nicholas J.

AU - McDonnell, Jennifer Wellman

AU - Auricchio, Alberto

AU - High, Katherine A.

AU - Bennett, Jean

PY - 2008/5/22

Y1 - 2008/5/22

N2 - Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and although the occurrence was considered to be an adverse event, the patient had some return of retinal function. Although the follow-up was very short and normal vision was not achieved, this study provides the basis for further gene therapy studies in patients with LCA.

AB - Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hRPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and although the occurrence was considered to be an adverse event, the patient had some return of retinal function. Although the follow-up was very short and normal vision was not achieved, this study provides the basis for further gene therapy studies in patients with LCA.

UR - http://www.scopus.com/inward/record.url?scp=44249085878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44249085878&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa0802315

DO - 10.1056/NEJMoa0802315

M3 - Article

VL - 358

SP - 2240

EP - 2248

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 21

ER -